Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pitolisant for EDS in OSA patients treated with nCPAP
NCT01071876Phase 3Completed
- Sponsor
- Bioprojet
- Start
- Aug 2011
- Primary completion
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pitolisant in Excessive Daytime Sleepiness (EDS), sponsored by Bioprojet. Started Aug 2011; status: completed.
02
Drugs
pitolisant
03
Conditions
Excessive Daytime Sleepiness (EDS)
Beyond the preview
Go deeper on NCT01071876.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01071876.